
News|Articles|December 25, 2024
Top 5 Print Publication Articles of 2024
Author(s)MHE Staff
Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines being developed for other diseases outside of COVID-19.
Advertisement
- mRNA Vaccine Momentum
The success of mRNA vaccines against COVID-19 has led to a surge of mRNA vaccines being developed for other diseases.Read here - New Treatments to Lower Lipoprotein(a)
Lipoprotein(a) is a cardiovascular disease risk factor that does not change with diet and exercise. There are no FDA-approved treatments, but two candidates are in phase 3 trials.Read here - 2024 Formulary Moves
The large pharmacy benefit managers have switched up their coverage of biosimilars, especially the biosimilars to Humira (adalimumab).Read here - Another Toxicity of Cancer Treatment
Time can be especially precious for people with advanced cancer. Researchers and clinicians are beginning to consider “time toxicity” as another aspect of treatment that burdens patients and their loved ones.Read here - The Leap to Self-Insurance
A growing proportion of small- and medium-sized employers are self-insuring. But with self-insurance, comes fiduciary responsibility and possible scrutiny.Read here
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
PBM reform. It has finally happened
3
TrumpRx launches; some experts question its long-term value
4
FDA issues draft guidance on MRD and complete response as primary endpoints for accelerated multiple myeloma drug approvals
5

























